Through quantification of immunofluorescence signals, our data revealed a 50% reduction in fibronectin signal and collagen type I staining in the hearts of Enalapril-treated UUO mice, compared to the untreated UUO/CKD mice (Fig. 8B). This evidence concerns the gene FN1 and chronic kidney disease.